Status | Study |
Active, not recruiting |
Study Name: Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi Date: 2012-02-06 Interventions: Drug: fludarabine phosphate Gi |
Recruiting |
Study Name: A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies Condition: Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Date: 2011-06-27 Interventions: Drug: Fludarabine Given IV |
Not yet recruiting |
Study Name: Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT) Condition: Acute Leukemias Chronic Leukemias Myelodysplastic Syndrome Date: 2011-04-20 Interventions: Drug: Busulfan/Cyclophosphamide Conditioning regimen: |
Active, not recruiting |
Study Name: Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia Condition: Acute Myelogenous Leukemia Myelodysplastic Syndrome Date: 2009-11-23 Interventions: Drug: Fludarabine Conditioning |
Withdrawn |
Study Name: Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias Condition: Myelodysplastic Syndrome Acute Myeloid Leukemia Myeloproli Date: 2009-02-26 Interventions: Drug: Clofarabine On Days 1, 2 |
Terminated |
Study Name: Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML Condition: Acute Myeloid Leukemia Juvenile Myelomonocytic Leukemia Date: 2008-04-29 Interventions: Drug: Gemtuzumab Ozogamicin Do |
Recruiting |
Study Name: Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood Condition: Myelodysplastic Syndromes Juvenile Myelomonocytic Leukemia Date: 2008-04-17 |
Completed |
Study Name: Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies Condition: Acute Lymphoblastic Leukemia Chronic Myelogenous Leukemia Date: 2008-04-14 Interventions: Other: NK Cell Infusion All pa |
Completed |
Study Name: Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors Condition: Leukemia, Myeloid, Acute Leukemia, Lymphocytic, Acute, T-Cell Date: 2008-03-14 Interventions: Procedure: Haploidentical donor derived natural killer cell infusion |
Terminated |
Study Name: Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation Condition: Leukemia Date: 2008-02-06 Interventions: Drug: cyclosporine Patients wi |